Aurobindo Pharma, Hyderabad-based manufacturer of generic and active pharmaceutical ingredients reported a net profit of Rs 103.2 crore for the quarter ended September 30, 2009, as against a net loss of Rs 38.4 crore during the corresponding period last year. Revenues were up 24.42 per cent to Rs 882.64 crore as compared with Rs 709.4 crore last year.
The company made a forex gain of Rs 3.7 crore during the quarter as against a loss of Rs 85.3 crore last year. Formulations sales increased 39.4 per cent to Rs 445.2 crore during the period as compared with Rs 319.3 crore, managing director K Nithyananda Reddy said in a release.
Aurobindo had three abbreviated new drug applications and 16 dossier filings during the quarter.
